Michael Gerber MD
Adult Cardiac Surgery, Minimally Invasive Thoracic Surgery, Thoracic Surgical Oncology
Physician
Join to View Full Profile
75 Pringle WaySte 1002Reno, NV 89502
Phone+1 775-323-7500
Fax+1 775-789-9208
Dr. Gerber is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- I am a board certified general surgeon and board eligible thoracic surgeon. I completed my general surgery training at the University of Florida (2014 - 2021) which included a two year research fellowship that focused on identifying diagnostic and prognostic tumor markers in pancreatic cancer. I then completed my thoracic surgery fellowship at he University of Arizona (2021 - 2023). My practice consists of general surgery and thoracic surgery with a special interest in thoracic oncology focusing on esophageal caner, lung cancer, chest wall tumors, and mediastinal tumors.
Education & Training
- University of Arizona College of Medicine-TucsonFellowship, Thoracic Surgery - Independent, 2021 - 2023
- University of FloridaResidency, Surgery, 2014 - 2021
- McGovern Medical School at UTHealthClass of 2014
Certifications & Licensure
- AZ State Medical License 2022 - 2027
- NV State Medical License 2023 - 2025
- American Board of Surgery Surgery
- American Board of Thoracic Surgery Thoracic and Cardiac Surgery
Publications & Presentations
PubMed
- 3 citationsTranscriptomic analysis of pancreatic adenocarcinoma specimens obtained from Black and White patients.Thomas G Biel, Svetlana Petrovskaya, Francesca Mascia, Tongzhong Ju, Lola Fashoyin-Aje
Plos One. 2023-01-01 - 4 citationsIndocyanine Green Use During Esophagectomy.Michael H Gerber, Stephanie G Worrell
Surgical Oncology Clinics of North America. 2022-10-01 - 22 citationsThe interleukin-1 axis and the tumor immune microenvironment in pancreatic ductal adenocarcinoma.Kelly M Herremans, Dominique D Szymkiewicz, Andrea N Riner, Riley P Bohan, Gerik W Tushoski
Neoplasia. 2022-06-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: